Articles
The Protecting Access to Medicare Act of 2014 (PAMA) for Laboratories: What You Need to Know
Congress passed the Protecting Access to Medicare Act (PAMA) in 2014. The purpose was to ensure millions of seniors could maintain access to critical health services, however the reality is that Congress was looking for an offset to previously mandated cuts to reimbursement for Physicians which were regularly exempted each year by Congress. PAMA “limited” cuts to laboratories at 10% in each of year one through three, and 15% in each of the following three years.
Read MoreThe True Cost of Traditional Lab-EHR Integrations
Automation and real-time data exchange are critical tools to advance quality care and reduce cost in healthcare. That said, more than 50% of diagnostic labs still operate using paper forms. The true cost of those paper forms is at least $30 per order.
Read MoreInformation Blocking: What You Need to Know
In 2016, the Federal Government enacted the 21st Century Cures Act (the Cures Act), to enhance patient access to their medical records, promote seamless communication across healthcare providers, and automate the secure exchange of patient information across disparate software platforms and systems.
Read MoreThe True Cost of Paper Forms
Despite national efforts and billions in funding to automate the healthcare industry, more than 50% of all lab tests are still processed on paper.
Read MoreHealthTrackRx selects Shadowbox to Enhance EHR Interoperability
Shadowbox is excited to announce that HealthTrackRx has selected Shadowbox to automate Electronic Health Records (“EHR”) and Lab Information Management Systems (“LIMS”) interoperability with their clinician customers, expanding their approach beyond traditional integration options.
Read MoreWith COVID Test Funding Gone, Diagnostic Labs Consider Their Next Move
Diagnostic laboratories are now beginning to navigate a post-COVID market, absent federal funding, and heightened testing demand.
Read MoreBrendan Kremer Joins Shadowbox Board of Directors
Brendan brings over 25 years of health system experience to the Shadowbox Board.
Read MoreShadowbox technology facilitated orders of Myriad Genetics prostate germline diagnostic, increasing pilot location volume by more than 800%
Shadowbox is excited to announce the results of a case study with leading genetic testing company, Myriad Genetics, that not only eliminated cumbersome manual work, but also increased medically appropriate prostate germline diagnostic test orders at pilot locations by more than 800%.
Read MoreHealthcare Has Outgrown the EHR
Accelerated by a worldwide pandemic and a tectonic shift toward telehealth and at-home care, the future of healthcare will demand the connection of multiple data sources to provide full visibility to a patient’s medical history.
Read MoreJames Budge Joins Shadowbox Board of Directors
“James is a visionary financial strategist, fundraising powerhouse and Silicon Valley veteran,” said Greg Stein, Shadowbox Co-founder and CEO. “We are ecstatic to welcome James to our board of directors where he is certain to elevate our approach to driving growth and value in the marketplace.”
Read More